Ali Amirkafi

Ali Amirkafi

Auto-generated profile, based on publicly available information

Ali Amirkafi

Preventive Medicine and Public Health Research Center, Psychosocial Health Research Institute, Department of Community and Family Medicine, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
EBEbrahim Babaee
Ebrahim Babaee
AAAli Amirkafi
Ali Amirkafi
ATArash Tehrani-Banihashemi
Arash Tehrani-Banihashemi
NSNeda SoleimanvandiAzar
Neda SoleimanvandiAzar
BEBabak Eshrati
Babak Eshrati
MNMarzieh Nojomi
Marzieh Nojomi
Background: Vaccination is a key intervention to prevent COVID-19. Many vaccines are administered globally, yet there is not much evidence regarding their safety and adverse effects. Iran also faces this challenge, especially as data regarding the Sputnik V vaccine is sparse. Therefore, the aim of this study is to determine the adverse effects of the most commonly used vaccines in Iran. Methods: Using a retrospective cohort study design, 6600 subjects aged 18 years or older who had received two doses of any of the three COVID-19 vaccines (Sinopharm, AstraZeneca, and Sputnik V) were selected using a random sampling method between March and August 2021. Subjects were asked about any adverse effects of the vaccines by trained interviewers via telephone interview. Vaccine-related adverse effects in individuals during the first 72 h and subsequently following both doses of the vaccines were determined. The demographic variables, type of administered vaccine, adverse effects, and history of the previous infection with COVID-19 were collected. Descriptive statistics (mean, standard deviation) and analytical statistics (Chi-squared and Wilcoxon tests) were performed at a 95% significance level using STATA software version 15 (STATA Corp, College Station, TX, USA). Results: From 6600 participants, 4775 responded (response rate = 72.3%). Of the participants, 1460 (30.6%) received the AstraZeneca vaccine, 1564 (32.8%) received the Sinopharm vaccine and 1751 (36.7%) received the Sputnik V vaccine. 2653 participants (55.56%) reported adverse effects after the first dose and 1704 (35.7%) after the second dose. Sputnik V caused the most adverse effects with 1449 (82.7%) vaccine recipients reporting symptoms after the first or second dose, compared with 1030 (70.5%) for AstraZeneca and only 585 (37.4%) for the Sinopharm vaccine. The most common adverse effects after the first dose were fatigue (28.37%), chill/fever (26.86%), and skeletal pain (22.38%). These three adverse effects were the same for the second dose, although their prevalence was lower. Conclusions: In this study, we demonstrate that the Sputnik V vaccine has the highest rate of adverse effects, followed by the AstraZeneca and Sinopharm vaccines. COVID-19 vaccines used in Iran are safe and there were no reports of serious adverse effects.

21 November 2023 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
NSNeda SoleimanvandiAzar
Neda SoleimanvandiAzar
AAAli Amirkafi
Ali Amirkafi
MSMohammadreza Shalbafan
Mohammadreza Shalbafan
SASeyyed Amir Yasin Ahmadi
Seyyed Amir Yasin Ahmadi
SAShadi Asadzandi
Shadi Asadzandi
MNMarzieh Nojomi
Marzieh Nojomi
Background: Obsessive Compulsive Disorder (OCD) symptoms, are among the serious mental health challenges that Health Care Workers (HCWs) faced during the COVID-19 pandemic. As these symptoms reduce the mental well-being and effectiveness of HCWs which are followed by poor health outcomes for patients, the aim of this systematic review and meta-analysis was to determine the prevalence of OCD symptoms among HCWs worldwide. Methods: PubMed, Google Scholar, Cochrane, Scopus, Web of Science, ProQuest, Emerald, and ERIC databases were searched using related keywords till the end of October 2021. Observational studies about the prevalence of OCD symptoms among healthcare workers during the COVID-19 pandemic were screened and evaluated. In order to assess the quality of studies, the Newcastle-Ottawa scale (NOS) checklist was used. The effect measure was the prevalence rate with a 95% confidence interval (CI). Results: A total of 7864 individuals from 11 studies were included. The range of OCD symptoms prevalence across these studies was from 0.07 to 0.47. Due to the high heterogeneity between the studies (I2 = 98.6%, P < 0.01), the random effects model was used. The pooled prevalence was 0.29 (95% CI: 0.22–0.38) based on logit transformed CI. Conclusions: The pooled prevalence of OCD symptoms was 29% among the HCWs during the COVID-19 pandemic. This prevalence was higher than the general population according to the pre-pandemic literature, but lower than the recent reports amid the pandemic. Psychosocial interventions are suggested to be designed and implemented in such conditions.

11 March 2021 in Immunopathologia Persa
Verified
Journal Article
Open access
PDF file
KSKamyar Shokraee
Kamyar Shokraee
HMHossein Mahdavi
Hossein Mahdavi
PPParsa Panahi
Parsa Panahi
FSFarnoosh Seirafianpour
Farnoosh Seirafianpour
AJAmir Mohammad Jahromizadeh
Amir Mohammad Jahromizadeh
AKAli Kabir
Ali Kabir
Introduction: This study aims to measure the diagnostic accuracy of chest computed tomography (CT) and reverse transcription polymerase chain reaction assay (RT-PCR) in COVID-19 in a systematic review and meta-analysis. Methods: PubMed, Scopus, Embase, and Google Scholar, WHO, SSRN, and MedRxiv have been searched on March 26, 2020 for all the alternative names of the disease and virus. Risk of bias assessment was based on QUADAS-2. Data from English-language studies after January 12, 2019 were pooled to calculate necessary diagnostic values and underwent diagnostic test accuracy, random-effects, proportions, and subgroup meta-analysis. Results: Pooled from 27 included studies, the sensitivity of chest CT was calculated 96.6%, specificity 22.5%, diagnostic odds ratio (DOR) 8.2, positive likelihood ratio (PLR) 1.2 (95% CI: 1.1-1.4), and negative likelihood ratio (NLR) 0.15 (95% CI: 0.1-0.3). The sensitivity for initial RT-PCR was 79.7%, the specificity 100%, and NLR 0.18. Conclusion: Considering the results, in order to diagnose COVID-19 (coronavirus disease 2019), it is recommended to initially performing chest CT to rule out the uninfected people. In suspicious cases, we suggest RT-PCR to confirm the disease. Performing serial RT-PCR instead of the one-time test is highly recommended, to let the viral loads reach the diagnostic levels, especially in cases of high clinical suspicion.

1 November 2022 in Quality & Quantity
Verified
Journal Article
Closed access
PDF file
SGSaideh Garousi
Saideh Garousi
AAAli Amirkafi
Ali Amirkafi
FMFaezeh Mohammadi
Faezeh Mohammadi
BGBehshid Garrusi
Behshid Garrusi

1 January 2024 in Health & Social Care in the Community
Verified
Journal Article
Open access
PDF file
BTBatool Tayefi
Batool Tayefi
ZRZahra Rampisheh
Zahra Rampisheh
NSNeda SoleimanvandiAzar
Neda SoleimanvandiAzar
EZElham Zandian
Elham Zandian
AAAli Amirkafi
Ali Amirkafi
MNMarzieh Nojomi
Marzieh Nojomi
Women’s health is the foundation of society’s health and it can be achieved only by addressing all aspects of their health. The aim of this systematic review and meta‐analysis is to investigate the prevalence of social health of Iranian women and related factors. The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) was used for reporting; the terms “social health,” “women,” “Iran,” and related keywords were searched in PubMed, Web of Science, Scopus, PsychoInfo, ProQuest and local databases, SID, Magiran, Irandoc, Elmnet, and Noormags up to August 2022. The published English or Persian quantitative primary studies which were conducted in Iran and reported social health or its dimensions among Iranian women were included. The studies were assessed by quality assessment tool for observational cohort and cross‐sectional studies developed by National Heart, Lung, and Blood Institute. From the 786 studies retrieved, 22 studies were finally included surveying different groups of women. Age, marital status, education, employment, socioeconomic status, social support, social participation, social trust, social security, communication skills, and self‐esteem were the factors affecting women’s social health. Five studies entered meta‐analysis and mean score of social health was 98.54 (95% CI: 87.56–109.51) and it was the lowest among women who were the head of households. Since women’s social health has been less considered in the society and research studies, further policies, legislations, and capacity building in mentioned fields are necessary. As social health is an important aspect of health, it is necessary for governments to address the known determinants of women’s social health in order to plan and promote the health of women, family, and finally society.

22 July 2020 in JMIR Research Protocols
Verified
Journal Article
Open access
SGSalime Goharinezhad
Salime Goharinezhad
SHSoodabeh Hoveidamanesh
Soodabeh Hoveidamanesh
SZSeyed Mohsen Zahraei
Seyed Mohsen Zahraei
MMMaziar Moradi-Lakeh
Maziar Moradi-Lakeh
BEBabak Eshrati
Babak Eshrati
AAAli Amirkafi
Ali Amirkafi
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: World Health Organization declared vaccine hesitancy as a global public health threat in 2019. Since even a slight reduction in vaccine coverage rates can lead to a decrease in herd immunity, it is imperative to explore the underlying factors affecting vaccine hesitancy. Objective: This qualitative study protocol aims to explore determinant factors influence vaccine hesitancy in Iran from the parent’s perspective. Methods: Descriptive-Interpretive Qualitative research will be conducted to gain an insight into vaccine hesitancy in the west of Tehran province in Iran. Participants in the study will be recruited vaccine-hesitant parents of children under 5 years old who will be recognized as being hesitant extracted from national health information system. The semi-structured interviews and in-depth questions will be performed both face-to-face in an open space such as park near to their homes and video-call because of COVID-19 pandemic and social distancing. Interviews will be conducted by a trained qualitative person. Transcribed data will be analyzed through thematic analysis. Results: This study is in progress and the literature review is ongoing. Ethics approval was obtained from the research ethics committee in the Iran University of Medical Sciences (Approval ID #IR.IUMS.REC.1399.273). Data collection process began in November 2021. The results of the study are expected to be presented by the end of the 2021 year. Conclusions: Understanding the factors that affect vaccine delivery in Islamic settings provides deep insights to allow health professionals to apply effective communication and behavioral strategies. Therefore, this study will generate fundamental and context-based information to guide the development of vaccine uptake guidelines for the healthcare settings in Iran.